Skip to main content
Kamile M. Weischedel

Kamile M. Weischedel, MD

Languages spoken: English, Turkish

Academic Information

Departments Adjunct - Psychiatry

Divisions: Adult Psychiatry

Academic Office Information

Board Certification

  • American Board of Psychiatry & Neurology (Psychiatry)
  • Educational Commission for Foreign Medical Graduates
  • National Board of Medical Examiners

Research Interests

  • Psychiatric Disease

Kamile Melek Weischedel, MD, Assistant Professor (Clinical), earned her medical degree at University of Istanbul. She then spent 3 years in psychiatry residency in her home country before she moved to the United States. She worked as a postdoc research associate at Yale University before coming to the University of Utah Department of Psychiatry to complete her residency training. During residency, Dr. Weischedel was involved in teaching medical students and fellow residents and her interest areas include neuromodulation (ECT, TMS, Ketamine), addiction psychiatry, teaching and tele-psychiatry. She was the Track IV Director for the University of Utah medical students between 2017 and 2021. She is board-certified in Psychiatry by the American Board of Psychiatry and Neurology.

Education History

Certification University of Utah
University of Utah David Eccles of School of Business
Post Graduate Training University of Utah
University of Utah
Residency Bakırköy Psychiatric Hospital
University of Istanbul

Selected Publications

Journal Article

  1. Tadler SC, Jones KG, Lybbert C, Huang JC, Jawish R, Solzbacher D, Kendrick EJ, Pierson MD, Weischedel K, Rana N, Jacobs R, Vonesh LC, Feldman DA, Larson C, Hoffman N, Jessop JE, Larson AL, Taylor NE, Odell DH, Kuck K, Mickey BJ (2023). Propofol for treatment resistant depression: A randomized controlled trial. (Read full article)
  2. Oka F, Weischedel K, Bakian A, Mickey BJ (2022). Treatment-Resistant Mood Disorders in LGBTQ People: A Retrospective Study of Clinical Features and Response to Electroconvulsive Therapy. J Clin Psychiatry, 83(4). (Read full article)
  3. Palmese LB, Ratliff JC, Reutenauer EL, Tonizzo KM, Grilo CM, Tek C (2013). Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorder. Compr Psychiatry, 54(3), 276-81. (Read full article)
  4. Ratliff JC, Palmese LB, Tonizzo KM, Chwastiak L, Tek C (2012). Contingency management for the treatment of antipsychotic-induced weight gain: a randomized controlled pilot study. Obes Facts, 5(6), 919-27. (Read full article)

Book Chapter

  1. Hershenberg R, Rapaport M, Weischedel K (2022). Identification and management of anxious depression in patients with treatment-resistant depression. In Hershenberg R|Rapaport M|Weischedel K (Ed.), Managing Treatment-Resistant Depression: Road to Novel Therapeutics (pp. 415-440). (Read full article)

Case Report

  1. Durns T, Rich B, Benson C, Mickey B, Weischedel K (2020). A Case of Biopharmaceutical-induced Catatonia and The Implication of a Novel Mechanism  . J ECT, 36(2), e29-e30.